The registration of clinical trials will help improve reliability of data generated, help clinicians interpret research, minimize duplication of trials, and prevent exposure of volunteers to potential risks. 1 The Clinical Trials Registry -India (CTRI) (www.ctri.in) hosted at the National Institute of Medical Statistics (NIMS), Indian Council of Medical Research (ICMR), New Delhi, was formally launched on 20 July 2007. This is a free online registry of clinical trials with the aim to encourage all clinical trials conducted in India to be prospectively registered before the enrollment of the first participant and to disclose details of the 20 mandatory items of the WHO International Clinical Trials Registry Platform (ICTRP) dataset and a few additional items. 2 Thus, the CTRI becomes a WHO ICTRP and International Committee of Medical Journal Editors (ICMJE) compliant primary register for India. Clinical trial has been defined by the ICMJE. 3 Within about 3 months of its launch the response received has been overwhelming with over 90 clinical trials already registered. But registration of trials is just a beginning. Active steps are on to sensitize researchers who actually conduct trials, funding agencies, ethics committee members, pharmaceutical companies, health professionals and medical journal editors on the need to register all trials that need registration. The WHO's ICTRP and ICMJE have drawn up clear guidelines on these issues. [4] [5] [6] However, only prospectively registered clinical trials will be considered for publication.
While participants of clinical trials volunteer with an altruistic motive, it is too well known that still all is not well in experiments involving human subjects. 7 There have been reports that trials have failed in their objective to carry out experiments fairly, report honestly and follow the ethical principles in India and abroad. 8 There have been several instances of selective reporting or not reporting at all depending upon the outcome of the trial and when financial interests are at stake. Despite best efforts to ensure transparency and honesty, most initiatives to discourage the conduct of unethical trials have largely been unsuccessful.
Attempts to regulate clinical trials through a system of record keeping at a public registry which would provide access to data on trials being carried out have not been very successful as trial registration is voluntary and there is reluctance of pharma companies to disclose data. As a step to ensure complete awareness of trial details, the ICMJE proposed comprehensive registration for clinical trials submitted for publication for the 12 member journals (Annals The ICMJE did not indicate a particular registry but any one that meets a set of minimum data.
With this background, the CTRI in association with the Indian Journal of Medical Research (IJMR) organized a meeting of editors of Indian biomedical journals to evolve a policy to be followed for publication of clinical trials in Indian biomedical journals. The meeting held at the ICMR on 9 October 2007 was attended by 12 editors of Indian biomedical journals. It was unanimously decided that the editors have the responsibility to promote the registration of all clinical trials being conducted in India and to urge researchers to register their trials within a stipulated time, to make the clinical trial data transparent and to enable results to be published.
On behalf of all biomedical journals published from India, we urge all those who are either conducting and/or planning to conduct clinical trials involving human subjects to register their trials in CTRI or in any primary clinical trial register. From January 2010 onwards, we will consider publication of a trial only if it has been registered prospectively if started in or after June 2008; trials undertaken before June 2008 need to be registered retrospectively.
